ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
ADMA Biologics reports 2020 executive compensation
By ExecPay News
Published: April 7, 2021
ADMA Biologics reported fiscal year 2020 executive compensation information on April 7, 2021.
In 2020, three executives at ADMA Biologics received on average a compensation package of $1.4M, a 5% increase compared to previous year.
Adam S. Grossman, Chief Executive Officer, received $2M in total, which increased by 15% compared to 2019. 31% of Grossman's compensation, or $600K, was in salary. Grossman also received $486K in bonus, $545K in option awards, $292K in stock awards, as well as $40K in other compensation.
James Mond, Chief Scientific Officer, received a compensation package of $1.2M, which decreased by 3% compared to previous year. 37% of the compensation package, or $440K, was in salary.
Brian Lenz, Chief Financial Officer, earned $1.1M in 2020, a 3% decrease compared to previous year.